Cost-effectiveness analysis of glecaprevir/pibrentasvir regimen for treating Chinese patients with chronic hepatitis C genotype 1 and genotype 2 infection - Zhou, Hui-Jun; Wu, Gang; Li, Ji-Ming; Naidoo, Nasheen; Xie, Yan-Xiang; Feng, Bo-Lan; Wang, Pei; Luo, Ji-Wei (Annals of Palliative Medicine, 2021)